Fifty years after the landmark 1964 US Surgeon General Report on Smoking and Health, smoking is deadlier than ever — now responsible for the deaths of 480,000 Americans each year.
RT Magazine spoke with GlaxoSmithKline about the launch of its latest respiratory product, BREO ELLIPTA, a once-daily ICS/LABA combination for the improvement of lung function and exacerbation control in COPD patients.
A new report from JAMA Internal Medicine estimates the total annual cost for the five most costly hospital-associated infactions (HAIs) to be $9.8 Billion, 30% of which is attributed to ventilator-associated pneumonia (VAP).
In the last 5 months, 20 U.S. states have passed legislation requiring newborn screenings for critical congenital heart disease (CCHD) using pulse oximetry, an inexpensive test effective at saving lives.
RT editorial director John Bethune discusses the Joint Commission’s National Patient Safety Goal (NPSG) on alarm management to combat alarm fatigue in hospital settings.
When it comes to health care, you might think that you can never have too much information. The more you know about a patient’s condition, after all, the better chance you have of successfully treating it. In practice, it’s not that simple.
Chief editor John Bethune introduces RT’s newest project: a microsite dedicated to patient monitoring in respiratory care.
RT editorial director John Bethune discusses one of the costliest obstacles that hospitals face in response to new health care regulations: reducing COPD readmissions.
As the use of mobile apps expands, will respiratory care start to use these tools in conjunction with therapy?